Has Carol Frank received payments from drug or device companies?

Yes. Drug and device makers reported $1,903 in general payments to Carol Frank across 119 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carol Frank did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carol Frank come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carol Frank

Internal Medicine · Coos Bay, ORNPI 1023049541

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $723 and has fallen 97.5% since, to $18 in 2025. Among internal medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,903in general payments, 2019–2025

Across 119 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$228
AstraZeneca$228
Novartis$180
GSK$170
E.r. Squibb & Sons, L.L.C.$143
Pfizer$137
plus $817 from 18 others

What the payments were for

Food & beverage$1,85297%
Education$513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	13	$228
AstraZeneca	13	$228
Novartis	9	$180
GSK	10	$170
E.r. Squibb & Sons, L.L.C.	20	$143
Pfizer	9	$137
Sanofi-aventis U.S. LLC	7	$126
Amarin Pharma, Inc.	5	$113
Novo Nordisk	5	$84
Lilly USA, LLC	3	$78
Kowa Pharmaceuticals America, Inc.	5	$67
Amgen	3	$61
Johnson & Johnson	2	$48
Astellas Pharma US Inc	2	$37
Otsuka America Pharmaceutical, Inc.	2	$34
Ultragenyx Pharmaceutical Inc.	2	$32
Teva Pharmaceuticals USA, Inc.	2	$25
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$20
Daiichi Sankyo Inc.	1	$20
Gilead	1	$20
Bayer	1	$14
Boehringer Ingelheim	1	$13
Organon	1	$13
Irhythm Technologies, Inc.	1	$12

How this compares

$1,903 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.

See all internal medicine providers in Oregon →

Other internal medicine in Coos Bay

Chad PfeferBeaverton$639K
Pranav ChandrashekarPortland$81K
Jonathan EdmistonBend$68K
Jessica CastlePortland$66K
Ellen Schiaffino PurvisGresham$66K
Steven ShawWhite City$58K
Stephen SpurgeonPortland$42K
Jane BabiarzPortland$30K
Andrew HarbisonPortland$29K
Marc UemuraEugene$20K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →